Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_assertion type Assertion NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_head.
- NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_assertion description "[The present case is unusual in four aspects: (i) it arose from a low-grade ganglioglioma in the absence of previous radiation or chemotherapy, which is the fourth reported case; (ii) the original tumor showed a high proliferative index on flow cytometry but a low Ki-67 labeling index, implying that the application of flow cytometry might play a certain role in predicting biological and clinical behavior of low grade gangliogliomas; (iii) p53 mutation and deletion appeared in the secondary glioblastoma, which was not shown in the original well-differentiated ganglioglioma; and (iv) the transformed glioblastoma showed p16 inactivation detected by methylation and deletion, which are relatively uncommon genetic events in secondary glioblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_provenance.
- NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_assertion evidence source_evidence_literature NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_provenance.
- NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_assertion SIO_000772 14629754 NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_provenance.
- NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_assertion wasDerivedFrom befree-2016 NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_provenance.
- NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_assertion wasGeneratedBy ECO_0000203 NP421297.RAgQchV2_towflxUGStgUMRFiqZBW6o9D2IsXaqTzsFHM130_provenance.